160 related articles for article (PubMed ID: 37889870)
1. Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma.
Li M; Liao K; Nowakowska M; Wehner M; Shih YT
J Manag Care Spec Pharm; 2023 Nov; 29(11):1232-1241. PubMed ID: 37889870
[No Abstract] [Full Text] [Related]
2. Disparity in checkpoint inhibitor utilization among commercially insured adult patients with metastatic lung cancer.
Li M; Liao K; Chen AJ; Cascone T; Shen Y; Lu Q; Shih YT
J Natl Cancer Inst; 2023 Mar; 115(3):295-302. PubMed ID: 36346180
[TBL] [Abstract][Full Text] [Related]
3. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
Jang SR; Nikita N; Banks J; Keith SW; Johnson JM; Wilson M; Lu-Yao G
JAMA Netw Open; 2021 Dec; 4(12):e2136823. PubMed ID: 34854905
[TBL] [Abstract][Full Text] [Related]
4. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults.
Schonfeld SJ; Tucker MA; Engels EA; Dores GM; Sampson JN; Shiels MS; Chanock SJ; Morton LM
JAMA Netw Open; 2022 Mar; 5(3):e223461. PubMed ID: 35315916
[TBL] [Abstract][Full Text] [Related]
5. Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer.
Malinowski C; Lei X; Zhao H; Giordano SH; Chavez-MacGregor M
JAMA Oncol; 2022 Jun; 8(6):863-870. PubMed ID: 35389432
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Initiation of Kidney Failure Treatment During the First 4 Months of the COVID-19 Pandemic.
Nguyen KH; Thorsness R; Hayes S; Kim D; Mehrotra R; Swaminathan S; Baranwal N; Lee Y; Rivera-Hernandez M; Trivedi AN
JAMA Netw Open; 2021 Oct; 4(10):e2127369. PubMed ID: 34618039
[TBL] [Abstract][Full Text] [Related]
7. Racial and ethnic disparities in access to and enrollment in high-quality Medicare Advantage plans.
Park S; Werner RM; Coe NB
Health Serv Res; 2023 Apr; 58(2):303-313. PubMed ID: 35342936
[TBL] [Abstract][Full Text] [Related]
8. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors.
Olateju OA; Zeng Z; Thornton JD; Mgbere O; Essien EJ
BMC Cancer; 2023 Jul; 23(1):655. PubMed ID: 37442992
[TBL] [Abstract][Full Text] [Related]
9. Association of Area-Level Socioeconomic Deprivation With Hypoglycemic and Hyperglycemic Crises in US Adults With Diabetes.
Kurani SS; Heien HC; Sangaralingham LR; Inselman JW; Shah ND; Golden SH; McCoy RG
JAMA Netw Open; 2022 Jan; 5(1):e2143597. PubMed ID: 35040969
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma.
Howell AV; Gebregziabher M; Thiers BH; Paulos CM; Wrangle JM; Hunt KJ; Wallace K
J Geriatr Oncol; 2021 Apr; 12(3):394-401. PubMed ID: 33132048
[TBL] [Abstract][Full Text] [Related]
11. Association of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors.
Howell AV; Gebregziabher M; Thiers BH; Graboyes EM; Paulos CM; Wrangle JM; Hunt KJ; Wallace K
J Geriatr Oncol; 2022 Sep; 13(7):1003-1010. PubMed ID: 35660090
[TBL] [Abstract][Full Text] [Related]
12. Exit Rates of Accountable Care Organizations That Serve High Proportions of Beneficiaries of Racial and Ethnic Minority Groups.
Lin SC; Maddox KEJ; Ryan AM; Moloci N; Shay A; Hollingsworth JM
JAMA Health Forum; 2022 Sep; 3(9):e223398. PubMed ID: 36218951
[TBL] [Abstract][Full Text] [Related]
13. Medicare Eligibility and Racial and Ethnic Disparities in Operative Fixation for Distal Radius Fracture.
Benítez TM; Ouyang Z; Khouri AN; Fahmy JN; Wang L; Chung KC
JAMA Netw Open; 2023 Dec; 6(12):e2349621. PubMed ID: 38153736
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer.
Wang SJ; Khullar K; Kim S; Yegya-Raman N; Malhotra J; Groisberg R; Crayton SH; Silk AW; Nosher JL; Gentile MA; Mehnert JM; Jabbour SK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020239
[TBL] [Abstract][Full Text] [Related]
15. Loss to follow-up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group.
Puthenpura V; Ji L; Xu X; Roth ME; Freyer DR; Frazier AL; Marks AM; Pashankar FD
Cancer; 2023 May; 129(10):1547-1556. PubMed ID: 36813754
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Differences in 30-Day Hospital Readmissions Among US Adults With Diabetes.
Rodriguez-Gutierrez R; Herrin J; Lipska KJ; Montori VM; Shah ND; McCoy RG
JAMA Netw Open; 2019 Oct; 2(10):e1913249. PubMed ID: 31603490
[TBL] [Abstract][Full Text] [Related]
17. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Care Management During Terminal Hospitalization Among Adults With Metastatic Cancer From 2010 to 2017.
Deeb S; Chino FL; Diamond LC; Tao A; Aragones A; Shahrokni A; Yerramilli D; Gillespie EF; Tsai CJ
JAMA Netw Open; 2021 Sep; 4(9):e2125328. PubMed ID: 34550384
[TBL] [Abstract][Full Text] [Related]
19. Differences in presentation, treatment, and outcomes among minority head and neck cancer patient groups in Los Angeles County.
Lin ME; Castellanos CX; Bagrodia N; West JD; Kokot NC
Am J Otolaryngol; 2024; 45(1):104031. PubMed ID: 37639986
[TBL] [Abstract][Full Text] [Related]
20. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
